Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Asset Writedowns and Impairment (2016 - 2023)

Historic Asset Writedowns and Impairment for BioCorRx (BICX) over the last 6 years, with Q1 2023 value amounting to $47980.0.

  • BioCorRx's Asset Writedowns and Impairment changed N/A to $47980.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $47980.0, marking a year-over-year change of. This contributed to the annual value of $47980.0 for FY2023, which is N/A changed from last year.
  • As of Q1 2023, BioCorRx's Asset Writedowns and Impairment stood at $47980.0.
  • BioCorRx's Asset Writedowns and Impairment's 5-year high stood at $47980.0 during Q1 2023, with a 5-year trough of -$1000.0 in Q1 2019.